BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3373480)

  • 1. Design, synthesis, and antineoplastic activity of 2'-deoxy-2'-methylidenecytidine.
    Takenuki K; Matsuda A; Ueda T; Sasaki T; Fujii A; Yamagami K
    J Med Chem; 1988 Jun; 31(6):1063-4. PubMed ID: 3373480
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.
    Lin TS; Luo MZ; Liu MC; Clarke-Katzenburg RH; Cheng YC; Prusoff WH; Mancini WR; Birnbaum GI; Gabe EJ; Giziewicz J
    J Med Chem; 1991 Aug; 34(8):2607-15. PubMed ID: 1652024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antitumor activity of a novel nucleoside, 4'-thio-2'-deoxy-2'-methylidenecytidine.
    Miura S; Tanaka M; Yoshimura Y; Satoh H; Sakata S; Machida H; Matsuda A; Sasaki T
    Biol Pharm Bull; 1996 Oct; 19(10):1311-5. PubMed ID: 8913503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical deoxygenation of tert-alcohols in 2'-branched-chain sugar pyrimidine nucleosides: synthesis and antileukemic activity of 2'-deoxy-2' (S)-methylcytidine.
    Matsuda A; Takenuki K; Itoh H; Sasaki T; Ueda T
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3967-70. PubMed ID: 3435995
    [No Abstract]   [Full Text] [Related]  

  • 5. Nucleosides and nucleotides. 97. Synthesis of new broad spectrum antineoplastic nucleosides, 2'-deoxy-2'-methylidenecytidine (DMDC) and its derivatives.
    Matsuda A; Takenuki K; Tanaka M; Sasaki T; Ueda T
    J Med Chem; 1991 Feb; 34(2):812-9. PubMed ID: 1995905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity evaluation of cytidine-5'-deoxy-5-fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2',3'-carbonates.
    Jhansi Rani V; Raghavendra A; Kishore P; Nanda Kumar Y; Hema Kumar K; Jagadeeswarareddy K
    Eur J Med Chem; 2012 Aug; 54():690-6. PubMed ID: 22796042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel prodrugs of 2'-deoxy-2'-methylidenecytidine activated by membrane dipeptidase overexpressed in tumor tissues.
    Kohchi Y; Hattori K; Oikawa N; Mizuguchi E; Isshiki Y; Aso K; Yoshinari K; Shirai H; Miwa M; Inagaki Y; Ura M; Ogawa K; Okabe H; Ishitsuka H; Shimma N
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2241-5. PubMed ID: 17306533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies on the antitumor and immunosuppressive effects of the new fluorouracil derivative N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and its parent drug 5'-deoxy-5-fluorouridine.
    Miwa M; Ishikawa T; Eda H; Ryu M; Fujimoto K; Ninomiya Y; Umeda I; Yokose K; Ishitsuka H
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):998-1003. PubMed ID: 2143107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel D-2'-deoxy-2'-C-difluoromethylene-4'-thiocytidine as a potential antitumor agent.
    Lim MH; Kim HO; Moon HR; Chun MW; Jeong LS
    Org Lett; 2002 Feb; 4(4):529-31. PubMed ID: 11843583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
    Yamagami K; Fujii A; Arita M; Okumoto T; Sakata S; Matsuda A; Ueda T; Sasaki T
    Cancer Res; 1991 May; 51(9):2319-23. PubMed ID: 2015596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N4-hydroxy-5-halogeno-2'-deoxycytidine S and their 5'-mono-phosphates as inhibitors of thymidylate synthase and in vitro antileukemic agents.
    Felczak K; Bretner M; Dzik JM; Gołos B; Zieliński Z; Rode W; Kulikowski T
    Adv Exp Med Biol; 1998; 431():617-21. PubMed ID: 9598139
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and biological activity of 2'-deoxy-4'-thio pyrimidine nucleosides.
    Secrist JA; Tiwari KN; Riordan JM; Montgomery JA
    J Med Chem; 1991 Aug; 34(8):2361-6. PubMed ID: 1652015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides.
    Obata T; Endo Y; Tanaka M; Uchida H; Matsuda A; Sasaki T
    Jpn J Cancer Res; 2001 Jul; 92(7):793-8. PubMed ID: 11473731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
    Hanaoka K; Suzuki M; Kobayashi T; Tanzawa F; Tanaka K; Shibayama T; Miura S; Ikeda T; Iwabuchi H; Nakagawa A; Mitsuhashi Y; Hisaoka M; Kaneko M; Tomida A; Wataya Y; Nomura T; Sasaki T; Matsuda A; Tsuruo T; Kurakata S
    Int J Cancer; 1999 Jul; 82(2):226-36. PubMed ID: 10389757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosides and nucleotides. 123. Synthesis of 1-(2-deoxy-2-isocyano-beta-D-arabinofuranosyl)cytosine and related nucleosides as potential antitumor agents.
    Matsuda A; Dan A; Minakawa N; Tregear SJ; Okazaki S; Sugimoto Y; Sasaki T
    J Med Chem; 1993 Dec; 36(26):4190-4. PubMed ID: 8277500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of 2'-deoxy-2'-methylidenecytidine (DMDC), a deoxycytidine analogue antineoplastic agent.
    Brindley CJ; Morrison R; Gordon RJ; Devlin AJ; van der Gaast A; Verweij L; Funaki T
    Clin Pharmacokinet; 2000 Jun; 38(6):475-91. PubMed ID: 10885585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid related compounds. 74. Synthesis and biological activity of 2'(and 3')-deoxy-2'(and 3')-methylenenucleoside analogues that function as mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase and/or ribonucleotide reductase.
    Robins MJ; Samano V; Zhang W; Balzarini J; De Clercq E; Borchardt RT; Lee Y; Yuan CS
    J Med Chem; 1992 Jun; 35(12):2283-93. PubMed ID: 1613752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.
    Ishikawa T; Utoh M; Sawada N; Nishida M; Fukase Y; Sekiguchi F; Ishitsuka H
    Biochem Pharmacol; 1998 Apr; 55(7):1091-7. PubMed ID: 9605432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthesis and biological activity of several 5-halo-5'-amino analogues of deoxyribopyrimidine nucleosides.
    Lin TS; Prusoff WH
    J Med Chem; 1978 Jan; 21(1):106-9. PubMed ID: 563459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.